Wells Fargo
INBS icon

Wells Fargo’s Intelligent Bio Solutions INBS Stock Holding History

Wells Fargo’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2
Closed -$72 – 7158
2024
Q1 		$72 Buy
2
+1
+100% +$41 ﹤0.01% 6734
2023
Q4 		$23 Buy
+1
New +$39 ﹤0.01% 7166
2023
Q3 		– Hold
0
– – – 7235
2023
Q2 		– Hold
0
– – – 7170
2023
Q1 		– Hold
0
– – – 7407
2022
Q4 		– Hold
0
– – – 7295
2022
Q3 		– Hold
0
– – – 6971
2022
Q2 		– Hold
0
– – – 7118
2022
Q1 		– Hold
0
– – – 7410
2021
Q4 		– Hold
0
– – – 7497
2021
Q3 		– Hold
0
– – – 7224
2021
Q2 		– Hold
0
– – – 7140
2021
Q1 		– Hold
0
– – – 7101

Other funds holding INBS

ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo's INBS Position: Q2 2024 in Review

Wells Fargo sold out of Intelligent Bio Solutions (INBS) in Q2 2024, closing a stake of 2 shares — an estimated $72 sold.

Wells Fargo first reported a position in INBS in Q4 2023 and held it in 2 quarters. The position peaked at $72 in Q1 2024. 8 funds tracked by Wall St. Rank hold INBS as of Q2 2024.

  • Wells Fargo reported no remaining Intelligent Bio Solutions position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 2 Intelligent Bio Solutions shares in Q2 2024, an estimated $72.
  • Wells Fargo first reported a position in Intelligent Bio Solutions in Q4 2023 and held it in 2 quarters.
  • Wells Fargo's Intelligent Bio Solutions position peaked at $72 in Q1 2024.
  • 8 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.